248 related articles for article (PubMed ID: 30299430)
1. Pharmacokinetic Characteristics and Limited Sampling Strategies for Therapeutic Drug Monitoring of Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections.
Kim EJ; Oh J; Lee K; Yu KS; Chung JY; Hwang JH; Nam EY; Kim HS; Kim M; Park JS; Song KH; Kim ES; Song J; Kim HB
Ther Drug Monit; 2019 Feb; 41(1):102-106. PubMed ID: 30299430
[TBL] [Abstract][Full Text] [Related]
2. Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration.
Imberti R; Cusato M; Villani P; Carnevale L; Iotti GA; Langer M; Regazzi M
Chest; 2010 Dec; 138(6):1333-9. PubMed ID: 20558557
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and pharmacokinetics of colistimethate sodium and colistin in critically ill patients in an Indian hospital with high endemic rates of multidrug-resistant Gram-negative bacterial infections: A prospective observational study.
Moni M; Sudhir AS; Dipu TS; Mohamed Z; Prabhu BP; Edathadathil F; Balachandran S; Singh SK; Prasanna P; Menon VP; Patel T; Patel P; Kaye KS; Menon VP
Int J Infect Dis; 2020 Nov; 100():497-506. PubMed ID: 32781161
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection.
Karnik ND; Sridharan K; Jadhav SP; Kadam PP; Naidu RK; Namjoshi RD; Gupta V; Gore MS; Surase PV; Mehta PR; Gogtay JA; Thatte UM; Gogtay NJ
Eur J Clin Pharmacol; 2013 Jul; 69(7):1429-36. PubMed ID: 23508665
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.
Plachouras D; Karvanen M; Friberg LE; Papadomichelakis E; Antoniadou A; Tsangaris I; Karaiskos I; Poulakou G; Kontopidou F; Armaganidis A; Cars O; Giamarellou H
Antimicrob Agents Chemother; 2009 Aug; 53(8):3430-6. PubMed ID: 19433570
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic evaluation of colistin sodium.
Michalopoulos AS; Karatza DC; Gregorakos L
Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):245-55. PubMed ID: 21128824
[TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis.
Jacobs M; Grégoire N; Mégarbane B; Gobin P; Balayn D; Marchand S; Mimoz O; Couet W
Antimicrob Agents Chemother; 2016 Jan; 60(3):1788-93. PubMed ID: 26729492
[TBL] [Abstract][Full Text] [Related]
8. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.
Luque S; Escaño C; Sorli L; Li J; Campillo N; Horcajada JP; Salas E; Grau S
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559275
[TBL] [Abstract][Full Text] [Related]
9. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria.
Zaidi ST; Al Omran S; Al Aithan AS; Al Sultan M
J Clin Pharm Ther; 2014 Jun; 39(3):272-6. PubMed ID: 24593154
[TBL] [Abstract][Full Text] [Related]
11. New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale.
Grégoire N; Mimoz O; Mégarbane B; Comets E; Chatelier D; Lasocki S; Gauzit R; Balayn D; Gobin P; Marchand S; Couet W
Antimicrob Agents Chemother; 2014 Dec; 58(12):7324-30. PubMed ID: 25267662
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
[TBL] [Abstract][Full Text] [Related]
13. Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.
Karaiskos I; Friberg LE; Pontikis K; Ioannidis K; Tsagkari V; Galani L; Kostakou E; Baziaka F; Paskalis C; Koutsoukou A; Giamarellou H
Antimicrob Agents Chemother; 2015 Dec; 59(12):7240-8. PubMed ID: 26369974
[TBL] [Abstract][Full Text] [Related]
14. Successful Colistin Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infection Using a Rapid Method for Determination of Colistin in Plasma: Usefulness of Therapeutic Drug Monitoring.
Yamada T; Ishiguro N; Oku K; Higuchi I; Nakagawa I; Noguchi A; Yasuda S; Fukumoto T; Iwasaki S; Akizawa K; Furugen A; Yamaguchi H; Iseki K
Biol Pharm Bull; 2015; 38(9):1430-3. PubMed ID: 26155936
[TBL] [Abstract][Full Text] [Related]
15. Steady-state pharmacokinetic and pharmacodynamic profiling of colistin in critically ill patients with multi-drug-resistant gram-negative bacterial infections, along with differences in clinical, microbiological and safety outcome.
Ram K; Sheikh S; Bhati RK; Tripathi CD; Suri JC; Meshram GG
Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):128-140. PubMed ID: 33245629
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic analysis of colistin in burn patients.
Lee J; Han S; Jeon S; Hong T; Song W; Woo H; Yim DS
Antimicrob Agents Chemother; 2013 May; 57(5):2141-6. PubMed ID: 23439640
[TBL] [Abstract][Full Text] [Related]
17. The Use of Colistin for the Treatment of Multidrug-resistant Gram-negative Infections in Neonates and Infants: A Review of the Literature.
Nakwan N; Chokephaibulkit K; Imberti R
Pediatr Infect Dis J; 2019 Nov; 38(11):1107-1112. PubMed ID: 31469781
[TBL] [Abstract][Full Text] [Related]
18. Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill.
Mohamed AF; Karaiskos I; Plachouras D; Karvanen M; Pontikis K; Jansson B; Papadomichelakis E; Antoniadou A; Giamarellou H; Armaganidis A; Cars O; Friberg LE
Antimicrob Agents Chemother; 2012 Aug; 56(8):4241-9. PubMed ID: 22615285
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of colistin in patients with multidrug-resistant Gram-negative infections: A pilot study.
Gautam V; Shafiq N; Mouton JW; Malhotra S; Kaur S; Ray P
Indian J Med Res; 2018 Apr; 147(4):407-412. PubMed ID: 29998877
[TBL] [Abstract][Full Text] [Related]
20. Greater optimisation of pharmacokinetic/pharmacodynamic parameters through a loading dose of intravenous colistin in paediatric patients.
Wacharachaisurapol N; Phasomsap C; Sukkummee W; Phaisal W; Chanakul A; Wittayalertpanya S; Chariyavilaskul P; Puthanakit T
Int J Antimicrob Agents; 2020 Jun; 55(6):105940. PubMed ID: 32179149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
